5-hydroxytryptamine and noradrenaline. Ann. NY Acad. Sci. 863,
252–263.
Hua X. Y., Hayes C. S., Hofer A., Fitzsimmons B., Kilk K., Langel U.,
Bartfai T. and Yaksh T. L. (2004) Galanin acts at GalR1 receptors
in spinal antinociception: synergy with morphine and AP-5.
J. Pharmacol. Exp. Ther. 308, 574–582.
Jacoby A. S., Hort Y. J., Constantinescu G., Shine J. and Iismaa T. P.
(2002) Critical role for GALR1 galanin receptor in galanin regulation of neuroendocrine function and seizure activity. Mol. Brain
Res. 107, 195–200.
Kehr J., Yoshitake T., Wang F.-H., Razani H., Gimenez-Lort L., Jansson
A. and Yamaguchi M. (2002) Galanin is a potent in vivo modulator
of mesencephalic serotonergic neurotransmission. Neuropsychopharmacology 27, 341–356.
Kerekes N., Mennicken F., O'Donnell D., Ho ̈ kfelt T. and Hill R. H.
(2003) Galanin increases membrane excitability and enhances
Ca2+ currents in adult, acutely dissociated dorsal root ganglion
neurons. Eur. J. Neurosci. 11, 2957–2966.
Kokaia M., Holmberg K., Nanobashvili A. et al. (2001) Suppressed
kindling epileptogenesis in mice with ectopic overexpression of
galanin. Proc. Natl Acad. Sci. USA 98, 14 006–14 011.
Lanfumey L. and Hamon M. (2000) Central 5-HT1A receptors: regional
distribution and functional characteristics. Nucl. Med. Biol. 27,
429–435.
Lin E. J., Richichi C., Young D., Baer K., Vezzani A. and During M. J.
(2003) Recombinant AAV-mediated expression of galanin in rat
hippocampus suppresses seizure development. Eur. J. Neurosci.
18, 2087–2092.
Liu H. X., Brumovsky P., Schmidt R., Brown W., Payza K., Hodzic L.,
Pou C., Godbout C. and Ho ̈ kfelt T. (2001) Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal
cord: selective actions via GalR1 and GalR2 receptors. Proc. Natl
Acad. Sci. USA 98, 9960–9964.
Lu X., Barr A. M., Kinney J. W., Sanna P., Conti B., Behrens M. M. and
Bartfai T. (2005a) A role of galanin in antidepressant actions with a
focus on the dorsal raphe nucleus. Proc. Natl Acad. Sci. USA 102,
874–879.
Lu X., Mazarati A. M., Sanna P., Shinmei S. and Bartfai T. (2005b)
Distribution and differential regulation of galanin receptor subtypes
in rat brain: effects of seizure activity. Neuropeptides 39, 147–152.
Mauler F., Fahrig T., Horvath E. and Jork R. (2001) Inhibition of evoked
glutamate release by the neuroprotective 5-HT(1A) receptor
agonist BAY x 3702 in vitro and in vivo. Brain Res. 888, 151–157.
Mazarati A. and Lu X. (2005) Regulation of limbic status epilepticus by
hippocampal galanin type 1 and type 2 receptors. Neuropeptides
39, 277–280.
Mazarati A. M., Liu H., Soomets U., Sankar R., Shin D., Katsumori H.,
Langel U. and Wasterlain C. G. (1998) Galanin modulation of
seizures and seizure modulation of hippocampal galanin in animal
models of status epilepticus. J. Neurosci. 18, 10 070–10 077.
Mazarati A. M., Hohmann J. G., Bacon A., Liu H., Sankar R., Steiner R.
A., Wynick D. and Wasterlain C. G. (2000) Modulation of hippocampal excitability and seizures by galanin. J. Neurosci. 20,
6276–6281.
Mazarati A. M., Lu X., Kilk K., Langel U., Wasterlain C. G. and Bartfai
T. (2004a) Galanin type 2 receptors regulate neuronal survival,
susceptibility to seizures and seizure-induced neurogenesis in the
dentate gyrus. Eur. J. Neurosci. 19, 3235–3244.
